 REDWOOD CITY, Calif., Nov. 20, 2020 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective November 19, 2020, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 140,500 shares of the common stock of the Company to 10 newly hired non-officer employees, with a per share exercise price of 17.92, the closing trading price on the grant date. 